|Bid||6.21 x 1100|
|Ask||6.23 x 1100|
|Day's Range||6.18 - 6.28|
|52 Week Range||5.87 - 15.12|
|Beta (5Y Monthly)||0.38|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 14, 2023 - Nov 29, 2023|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||27.60|
Finch Therapeutics Group, Inc. (FNCH) delivered earnings and revenue surprises of -12.50% and 90.80%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Actinium (ATNM) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.